missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Human/Mouse/Rat XPD Antibody, R&D Systems™

Goat Polyclonal Antibody
Brand: R&D Systems AF3296-SP
This item is not returnable.
View return policy
Description
XPD Polyclonal specifically detects XPD in Human, Mouse, Rat samples. It is validated for Western Blot.
Specifications
| XPD | |
| Polyclonal | |
| Unconjugated | |
| Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied as a 0.2 μm filtered solution in PBS. with No Preservative | |
| Basic transcription factor 2 80 kDa subunit, BTF2 p80, COFS2, CXPD, DNA excision repair protein ERCC-2, DNA repair protein complementing XP-D cells, EC 3.6.1, EC 3.6.4.12, EM9, EM9TFIIH basal transcription factor complex 80 kDa subunit, ERCC2, excision repair cross-complementing rodent repair deficiency, complementationgroup 2, MAG, MGC102762, MGC126218, MGC126219, TFIIH 80 kDa subunit, TFIIH basal transcription factor complex helicase subunit, TFIIH basal transcription factor complex helicase XPD subunit, TTD, xeroderma pigmentosum complementary group D, Xeroderma pigmentosum group D-complementing protein, XPDC, XPDTFIIH p80 | |
| Goat | |
| Affinity Purified | |
| RUO | |
| 2068 | |
| Reconstitute at 0.2 mg/mL in sterile PBS. | |
| Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70 degreesC as supplied. 1 month, 2 to 8 degreesC under sterile conditions after reconstitution. 6 months, -20 to -70 degreesC under sterile conditions after reconstitution. |
| Western Blot | |
| LYOPH | |
| Western Blot 0.5 ug/mL | |
| P18074 | |
| ERCC2 | |
| E. coli-derived recombinant human XPD Met1-Gly360 Accession # P18074 | |
| 25 μg | |
| Primary | |
| Detects human, mouse, and rat XPD in Western blots. | |
| Human, Mouse, Rat | |
| IgG |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
For Research Use Only
Spot an opportunity for improvement?Share a Content Correction